title: Activation of G-protein-coupled receptors and thyroid malignant tumors: the jury is still out.
authors.forename: Robert F
authors.initials: RF
authors.lastname: Gagel
mesh_terms: D000818:Animals; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000494:pharmacology; D018278:Carcinoma, Neuroendocrine; D017277:Drug Approval; D015507:Drugs, Investigational / Q000009:adverse effects* / Q000494:pharmacology; D019317:Evidence-Based Medicine; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology; D000069450:Liraglutide; D050505:Mutant Proteins / Q000819:agonists / Q000378:metabolism; D009363:Neoplasm Proteins / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D012516:Osteosarcoma / Q000139:chemically induced / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000819:agonists* / Q000235:genetics / Q000378:metabolism; D018027:Receptors, Glucagon / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D019379:Teriparatide / Q000009:adverse effects / Q000494:pharmacology; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000139:chemically induced* / Q000378:metabolism; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D050071:Bone Density Conservation Agents; D015507:Drugs, Investigational; C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D050505:Mutant Proteins; D009363:Neoplasm Proteins; D043562:Receptors, G-Protein-Coupled; D018027:Receptors, Glucagon; D019379:Teriparatide; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1